share_log

Prenetics Global (NASDAQ:PRE) Stock Price Down 24.4%

Defense World ·  Nov 25, 2022 15:41

Prenetics Global Limited (NASDAQ:PRE – Get Rating) shares traded down 24.4% during mid-day trading on Thursday . The company traded as low as $1.24 and last traded at $1.70. 548,995 shares changed hands during trading, an increase of 1,667% from the average session volume of 31,061 shares. The stock had previously closed at $2.25.

Prenetics Global Stock Down 24.4 %

The business has a fifty day moving average price of $3.25.

Get Prenetics Global alerts:

Prenetics Global (NASDAQ:PRE – Get Rating) last released its quarterly earnings results on Friday, September 9th. The company reported $0.04 earnings per share for the quarter. The business had revenue of $51.72 million during the quarter. Analysts anticipate that Prenetics Global Limited will post -2.99 earnings per share for the current year.

Institutional Trading of Prenetics Global

A hedge fund recently bought a new stake in Prenetics Global stock. NINE MASTS CAPITAL Ltd purchased a new stake in Prenetics Global Limited (NASDAQ:PRE – Get Rating) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 49,949 shares of the company's stock, valued at approximately $202,000. NINE MASTS CAPITAL Ltd owned approximately 0.11% of Prenetics Global as of its most recent SEC filing.

About Prenetics Global

(Get Rating)

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test.

Further Reading

  • Get a free copy of the StockNews.com research report on Prenetics Global (PRE)
  • Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
  • Is the 60/40 Portfolio Mix Still in Vogue?
  • Microsoft Shares: Is it Time to Back Up the Truck?
  • Three CBD Stocks to Dominate a Budding Industry
  • Institutional Support for Analog Devices Remains High

Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment